Avantax Planning Partners, Inc. Novartis Ag Transaction History

Avantax Planning Partners, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$82.14 - $91.0 $218,492 - $242,060	-2,660 Closed	0 $0
Q2 2020 Jul 15, 2020	BUY	$80.93 - $91.1 $215,273 - $242,325	2,660 New	2,660 $232,000
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $77,637 - $86,449	-1,054 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $70,554 - $81,611	1,054 New	1,054 $91,000
Q2 2018 Aug 13, 2018	SELL	$64.91 - $73.36 $140,659 - $158,971	-2,167 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $152,535 - $182,353	2,167 New	2,167 $172,000
Q4 2017 Feb 09, 2018	SELL	$72.33 - $77.64 $187,913 - $201,708	-2,598 Closed	0 $0
Q3 2017 Oct 19, 2017	BUY	$74.14 - $77.27 $192,615 - $200,747	2,598	2,598 $223,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Planning Partners, Inc. with notifications on news.